Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Rituximab in the Treatment of Idiopathic Membranous Nephropathy

NCT00425217 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT00425217
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00425217 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Rituximab in the Treatment of Idiopathic Membranous Nephropathy
Lead sponsor
Mayo Clinic
Phase
Phase 2/3
Overall status
Completed
Start date
August 31, 2004
Completion date
April 30, 2007
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

membranous nephropathy